Anthropic is moving its AI from the office into the laboratory. The company has launched Claude for Life Sciences, a version of its artificial intelligence tooling tailored to research teams and connected directly to the platforms scientists already use.
The launch includes integrations with Benchling, BioRender, PubMed and Scholar Gateway, so researchers can query literature, work with experimental records and draft documentation without stitching together separate tools by hand.
Anthropic named pharmaceutical heavyweights Novo Nordisk and Sanofi among the organizations adopting or supporting the effort, alongside contract research firms and Stanford researchers — a signal the company is chasing regulated, high-value scientific workflows rather than casual users.
The product was built with input from biomedical engineers, a molecular biologist and a former biotech chief of staff, and sits on the same enterprise distribution rails as the rest of Anthropic's business offering through the major cloud marketplaces.
The launch sharpens the AI industry's contest for science: drug discovery and lab automation are among the few domains where customers will pay premium prices for models that demonstrably save expert time.
